FDA Clears Israeli-Developed Standing Robotic Wheelchair for U.S. Distribution

(NoCamels) UPnRIDE Robotics announced on Thursday that the U.S. Food and Drug Administration (FDA) has cleared its Robotic Standing Wheelchair for marketing and use in the U.S. The device is suitable for most wheelchair users. Dr. Amit Goffer, founder and president of UPnRIDE Robotics, a quadriplegic himself following a vehicle accident, is also the founder of ReWalk Robotics, the company that developed an FDA-approved wearable robotic exoskeleton that enables individuals with spinal cord injury to stand upright and walk. He says, "All people confined to a wheelchair should have access to enhanced mobility and enjoy the many health benefits associated with the ability to perform everyday tasks in a standing position."


2020-02-28 00:00:00

Full Article

BACK

Visit the Daily Alert Archive